344 related articles for article (PubMed ID: 25230350)
1. Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
Liu C; Liu Y; Ye S; Liu L; Zhang W; Wu M
J Ocul Pharmacol Ther; 2014 Dec; 30(10):831-6. PubMed ID: 25230350
[TBL] [Abstract][Full Text] [Related]
2. Pupil size with and without adrenaline with diclofenac use before cataract surgery.
Ong-Tone L; Bell A
J Cataract Refract Surg; 2009 Aug; 35(8):1396-400. PubMed ID: 19631127
[TBL] [Abstract][Full Text] [Related]
3. Topical ketorolac tromethamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery.
Srinivasan R; Madhavaranga
J Cataract Refract Surg; 2002 Mar; 28(3):517-20. PubMed ID: 11973101
[TBL] [Abstract][Full Text] [Related]
4. Systemic diclofenac sodium to maintain mydriasis during phacoemulsification.
Sidiki SS; Wykes WN
J Cataract Refract Surg; 1998 May; 24(5):684-8. PubMed ID: 9610454
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of mydriasis with one bolus of epinephrine injection during phacoemulsification.
Liou SW; Chen CC
J Ocul Pharmacol Ther; 2001 Jun; 17(3):249-53. PubMed ID: 11436945
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis.
Roberts CW
J Cataract Refract Surg; 1996; 22 Suppl 1():780-7. PubMed ID: 9279672
[TBL] [Abstract][Full Text] [Related]
7. Redilatation with intracameral mydriatics in phacoemulsification surgery.
Bäckström G; Behndig A
Acta Ophthalmol Scand; 2006 Feb; 84(1):100-4. PubMed ID: 16445447
[TBL] [Abstract][Full Text] [Related]
8. [The effect of diclofenac sodium and indomethacin used locally for maintenance of pupillary dilatation during cataract surgery].
Guzińska M; Kałuzny J; Florek G
Klin Oczna; 1998; 100(1):19-22. PubMed ID: 9685793
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone and flurbiprofen drops to maintain mydriasis during phacoemulsification cataract surgery.
Shaikh MY; Mars JS; Heaven CJ
J Cataract Refract Surg; 2003 Dec; 29(12):2372-7. PubMed ID: 14709299
[TBL] [Abstract][Full Text] [Related]
10. [Comparative efficacy of 0.1% indomethacin eyedrops, 0.03% flurbiprofen eyedrops and placebo for maintaining peroperative mydriasis].
Allaire C; Lablache Combier M; Trinquand C; Bazin R
J Fr Ophtalmol; 1994; 17(2):103-9. PubMed ID: 8176180
[TBL] [Abstract][Full Text] [Related]
11. Preventing perioperative miosis in cataract surgery.
Chatterjee S
J Cataract Refract Surg; 2003 Mar; 29(3):423. PubMed ID: 12662990
[No Abstract] [Full Text] [Related]
12. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies.
Hovanesian JA; Sheppard JD; Trattler WB; Gayton JL; Malhotra RP; Schaaf DT; Ng E; Dunn SH
J Cataract Refract Surg; 2015 Oct; 41(10):2060-8. PubMed ID: 26703280
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Stewart R; Grosserode R; Cheetham JK; Rosenthal A
Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
[TBL] [Abstract][Full Text] [Related]
14. Topical naproxen sodium for inhibition of miosis during cataract surgery. Prospective, randomized clinical trials.
Papa V; Russo S; Russo P; Di Bella A; Santocono M; Milazzo G;
Eye (Lond); 2002 May; 16(3):292-6. PubMed ID: 12032720
[TBL] [Abstract][Full Text] [Related]
15. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery.
Rodríguez-García A; Hernández-Camarena JC; López-Jaime GR; Nava-García JA
J Refract Surg; 2017 Apr; 33(4):236-242. PubMed ID: 28407163
[TBL] [Abstract][Full Text] [Related]
16. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
Solomon KD; Turkalj JW; Whiteside SB; Stewart JA; Apple DJ
Arch Ophthalmol; 1997 Sep; 115(9):1119-22. PubMed ID: 9298051
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery.
Dubois V; Wittles N; Lamont M; Madge S; Luck J
BMC Ophthalmol; 2006 Nov; 6():36. PubMed ID: 17129389
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new preoperative ophthalmic solution.
Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of preoperative nonsteroidal anti-inflammatory drug and the re-dilation technique in minimizing miosis after femtosecond laser in cataract surgery.
Ventura BV; Rabello LP; Silvestre F; Ventura MC
Arq Bras Oftalmol; 2019; 82(2):111-118. PubMed ID: 30698231
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the intracameral dilation regimen for cataract surgery: prospective randomized comparison of 2 solutions.
Myers WG; Shugar JK
J Cataract Refract Surg; 2009 Feb; 35(2):273-6. PubMed ID: 19185242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
